This post is for doctors, practice managers and marketing leads who run Google Ads for elective, high-sensitivity specialties, namely IVF, bariatric surgery, cosmetic procedures and hair transplants, and who have seen ads disapproved without a clear reason. It maps the policy text to those specialties, shows which sections are actually relevant to a provider in India, and describes how to keep a log that tells you where your own copy fails.
A caution first. Policy pages change, and Google applies them partly through automated review. This map reflects the text I could read in October 2026. Treat it as a starting point and check the linked pages before launch. It is not legal advice, and it does not replace the advertising rules that apply to doctors under Indian law and the National Medical Commission's regulations.
Which Google policies apply, in plain terms
Healthcare ads touch four separate policies. People often blame the first when the cause is one of the others.
- Healthcare and medicines. The core page, Google's healthcare and medicines policy, covers prescription drug services, restricted drug terms, pharmaceutical manufacturers, unauthorised pharmacies, unapproved substances, experimental treatments, addiction services, abortion, birth control and fertility, and health insurance. It is the one with certification and country-specific sections.
- Unreliable claims. Under Google's misrepresentation rules, ads may not make inaccurate claims or claims that entice the user with an improbable result, even if the result is possible but presented as likely. This is the policy that bites on outcome language.
- Personalised advertising. Health is a sensitive interest category. Google's personalised advertising page says remarketing, Customer Match, audience expansion and lookalike segments are not supported for sensitive interest categories.
- Editorial and destination rules. Landing pages are reviewed as well. A compliant ad can still be disapproved because the page shows a restricted claim.
Most surprises come from the second and third. They are not specific to medicine, so they never appear in a search for "healthcare policy".
The specialty map
The table shows where each specialty is most likely to meet a rule. It is built from the policy text, not from a count of disapprovals.
| Specialty | Most relevant sections | What to watch in copy and pages |
|---|---|---|
| IVF and fertility | Birth control, fertility and testing (restricted in certain locations); prenatal gender determination (not allowed in India); unreliable claims | Any wording touching sex selection; success-rate claims presented as likely outcomes; testing services |
| Bariatric and weight loss | Unapproved substances; unreliable claims; restricted drug terms | Product claims, drug names, anything implying fast or certain weight loss |
| Cosmetic and aesthetic | Unreliable claims; personalised advertising; destination rules | Before-and-after imagery, "permanent" or "risk-free" wording, retargeting on procedure pages |
| Hair transplant | Restricted drug terms; unapproved substances; unreliable claims | Naming prescription medicines, "assured" density language, supplement claims |
Take each in turn.
IVF and fertility
The healthcare policy says Google does not allow promotion of products and services related to birth control, fertility and sexually transmitted infections in certain locations, and the page treats fertility testing and surrogacy services inside that group. The country-specific lists I could read do not give an India entry for the fertility group, so confirm the current status in the policy page and in the account's policy manager instead of assuming.
The India-specific entry I could verify is stronger: the page says pre-natal gender determination products are not allowed, citing a Supreme Court order. Any IVF copy that edges near selecting the sex of a child will be treated accordingly, and would also raise serious legal issues under Indian law. Keep this language out of ads, extensions and landing pages entirely.
The other IVF risk is outcome language. Success rates are common in fertility marketing. Under the unreliable claims rule, a figure presented as the likely result for the viewer is a risk. If you quote a rate, present it as a reported rate for a defined group, with the clinic's clinical team approving the wording and showing its source. See the article on IVF marketing to acquire patients sensitively for tone.
Bariatric surgery
The healthcare policy's unapproved substances section names examples such as hCG marketed for weight loss and products claiming to match prescription drugs. A surgical provider is not selling these, but a landing page that mentions a pharmacological alternative, a supplement or a medicine by brand name can bring the page into scope.
The risk for a surgeon is more often the claim. Language such as "lose weight fast", "permanent results" or specific kilograms lost presents an outcome as likely. Describe what the procedure is, who may be assessed for it, what the process involves and the fact that suitability is decided in consultation. Our page on bariatric surgery marketing discusses the context.
Cosmetic and aesthetic procedures
The healthcare policy text I could read does not address cosmetic procedures directly. That does not mean they are free of restriction. Unreliable claims and destination review apply, and personalised advertising rules prevent building remarketing audiences from sensitive interest categories. If a procedure page implies a medical condition, health targeting rules may be triggered.
Before-and-after imagery is where most teams stumble. Google's text on this in the pages I read was not specific, so rely on a cautious approach: no implied guarantee, no exaggerated comparison and consent for any image. Medical councils and advertising bodies may be stricter than Google here; see before-and-after content for cosmetic practices and the cosmetic surgery marketing guide.
Hair transplant
The relevant exposure is restricted drug terms and unapproved substances. Many hair clinics talk about finasteride, minoxidil or platelet-based add-on treatments. Google's April 2026 update to the India rules says advertisers targeting India may not promote prescription drugs in ads or landing pages unless they meet the new requirement, which is that an online pharmacy certified through LegitScript applies to Google. A clinic is not an online pharmacy, so the practical rule is to describe procedures, not products. More on specialty context is in our hair transplant marketing page.
Where certification enters
Certification is not required for every healthcare advertiser. The policy ties certification to categories such as online pharmacies, telemedicine in listed countries and pharmaceutical manufacturers. A hospital advertising its own services in India is generally not in those groups, but the question depends on the services you advertise. That is covered in the follow-up article on certification.
Build a disapproval log
Patterns published from another agency's accounts are of limited use, because the mix of copy, specialty and landing page differs. Build your own log instead. It takes ten minutes a week and, after a month, shows where you lose time.
For every disapproval or limited-eligibility notice, record:
- Date, account, campaign, ad group and ad ID.
- The policy name and the exact wording shown in the Policy Manager.
- The element that triggered it: headline, description, asset, destination, keyword or audience.
- What you changed, and the date.
- The review result and how long it took.
- Whether the same issue recurred in another ad group.
After four to six weeks, sort by trigger element. If most issues come from sitelinks or landing pages, fix the template. If most come from a single phrase, add it to a banned list in your copy brief. If a disapproval sits in a policy you do not think applies, appeal it, after checking the steps in the companion post on avoiding suspension.




